Wednesday, November 11, 2026 US Financial & Technology Edition
Market Edition
Updated 08:32 EDT
US Money · Insurance · SaaS
America Pulse Independent Financial & Technology News Wire
New York · Markets
Personal Finance · Investing
Banking · SaaS & Technology
Markets LIVE
Equity S&P 500 $749.37 ▼0.44% Equity Nasdaq $673.43 ▼0.87% Equity Dow $521.71 ▼0.31% Equity Gold $369.48 ▼2.65% Equity WTI Oil $141.58 ▼0.76% Equity Bonds 20Y $80.88 ▼1.32% Crypto BTC $73,815.95 ▼1.08% Crypto ETH $2,059.96 ▼2.64% Crypto XRP $1.06 ▼2.67%
Personal Finance Nov 11, 2026

SenesTech, Inc. (SNES) Q3 2026 Earnings Call Transcript

SenesTech, Inc., a company specializing in animal fertility control, recently conducted its conference call to review financial performance for the third quarter of the 2026 fiscal year. The discussion centered on the operational and financial results for the period that concluded on September 30, 2026. The event was moderated by Robert Blum of Lytham Partners, who introduced the primary speakers and outlined the structure of the presentation.

The leadership team representing SenesTech included Michael Edell, who holds the positions of President and Chief Executive Officer, and Tom Chesterman, the company’s Chief Financial Officer. These executives provided the core commentary regarding the firm’s trajectory and fiscal standing as of the end of the September quarter. The call was organized to include formal statements from management followed by a session dedicated to inquiries from participants.

Third Quarter Fiscal Year 2026 Financial Results

The timing of this report is critical for SenesTech as it navigates the competitive landscape of the pest management industry. By focusing on the three-month window ending September 30, 2026, the company aimed to provide transparency regarding its recent activities and its ability to meet internal targets. The call was recorded to ensure that the information shared by Edell and Chesterman would be available for subsequent review by stakeholders and the broader financial community.

SenesTech operates in a unique sector of the biotechnology and pest control markets, focusing on non-lethal methods to manage rodent populations. Their approach, which centers on fertility management rather than traditional extermination, represents a shift in how municipalities and private entities address infestations. The Q3 2026 results serve as a benchmark for the adoption of these sustainable technologies in a market traditionally dominated by lethal chemicals.

Management Team and Prepared Remarks

During the proceedings, Robert Blum emphasized the importance of the legal framework governing the information shared during the call. He noted that the remarks made by the SenesTech management team included forward-looking statements. These projections are subject to various risks and uncertainties, and they are protected under the safe harbor provisions established by the Private Securities Litigation Reform Act of 1995.

The company explicitly cited several key pieces of legislation that govern their public disclosures. These include Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. By referencing these statutes, the company clarified that any predictions or expectations regarding future performance are based on current management assumptions and are not guarantees of future results.

Forward Looking Statements and Safe Harbor

The inclusion of these legal disclosures is a standard but vital component of earnings calls for publicly traded companies like SenesTech. It ensures that investors understand the distinction between historical data, such as the results for the quarter ending September 30, and the speculative nature of future growth plans. The management team maintained this distinction throughout their presentation to provide a clear picture of the company’s current status.

As the call moved toward the question-and-answer portion, the focus remained on the specific data points from the third quarter. The interaction between the executive team and the call participants allowed for a deeper exploration of the financial health of the organization and its strategic direction heading into the final months of the 2026 fiscal year.

Source: seekingalpha.com · 2026-11-11

ipt>